You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 44 No. 8, August 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTION
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Carbamazepine Plasma Concentration

Relationship to Cognitive Impairment

Margaret O'Dougherty, PhD; Francis S. Wright, MD; Shareen Cox; Philip Walson, MD

Arch Neurol. 1987;44(8):863-867.


Abstract

• Neuropsychological function was assessed before and after carbamazepine monotherapy in children with newly diagnosed complex partial epilepsy. Simultaneous video-electroencephalographic monitoring examined the influence of subclinical abnormal electrical discharges on performance. Total and unbound plasma carbamazepine concentrations were examined in relation to changes in performance at low (carbamazepine level, ≤32 µmol/L [≤7.5 mg/L]) and moderate (carbamazepine level, >34 µmol/L [>8.0 mg/L]) drug levels. The data suggest a mild beneficial effect of carbamazepine on speeded eye-hand coordination and, at low drug levels, more rapid processing of items in memory. Efficiency of learning new information and memory-scanning rate displayed a concentration-dependent relationship with carbamazepine level, with poor performance significantly associated with higher carbamazepine plasma concentrations. Carbamazepine free levels were equivalent to total levels in predicting cognitive side effects.



Author Affiliations

From the Department of Pediatrics, Sections of Neurology (Drs O'Dougherty and Wright) and Clinical Pharmacology and Toxicology (Ms Cox and Dr Walson), The Ohio State University, Columbus.


Footnotes

Accepted for publication April 6, 1987.

Reprint requests to Department of Pediatrics, Children's Hospital, 700 Children's Dr, Columbus, OH 43205 (Dr O'Dougherty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Cognitive and Behavioral Effects of Carbamazepine in Children: Data From Benign Rolandic Epilepsy
Seidel and Mitchell
J Child Neurol 1999;14:716-723.
ABSTRACT  

Carbamazepine Withdrawal in Children With Previous Symptomatic Partial Epilepsy: Effects on Neuropsychologic Function
Riva and Devoti
J Child Neurol 1999;14:357-362.
ABSTRACT  

A Comparative Study of the Cognitive Effects of Phenytoin and Carbamazepine in Patients with Blunt Head Injury
Kirschner et al.
Neurorehabil Neural Repair 1991;5:169-174.
ABSTRACT  

Impaired Visual Contrast Sensitivity in Epileptic Patients Treated With Carbamazepine
Tomson et al.
Arch Neurol 1988;45:897-900.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.